Steven R. Hagen, SVP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 5,000 shares at $16.93 ($50K) on 2014-06-03, disclosed to the SEC on 2014-06-04.
Seasonal sale ($50k) by SVP Pharmaceutical Development & Mfg — this insider has traded AMRI in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.93 | 2,500 | $7K | 14.8% |
| 2 | $16.93 | 2,500 | $42K | 85.2% |
| Total | $9.93 avg | 5,000 | $50K | 100% |
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |